Ledger.Open graph →

SEC Form D · filed December 10, 2020

Edgewise Therapeutics, Inc

Offering

$95.0M

Sold

$95.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Boulder, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Kevin Koch · Tuscon, AZExec · Director Peter Thompson · New York, NYDirector Kenneth Harrison · San Diego, CADirector Jonathan Root · San Francisco, CADirector Alan Russell · Boulder, CODirector Michael Packamn · Jericho, NYDirector Gene Chen · Irvine, CAExec · Director Joseph Gissy · Manchester, MODirector Keystone 1031 LLC · Jericho, NYDirector David Wolenski · Irvine, CADirector Grant Mccullagh · Asheville, NCExec · Director Timothy Mcloughlin · Asheville, NCDirector Lee Lance · Asheville, NCDirector Walton Ward · San Marcos, TXDirector Erin Link · San Marcos, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗